Adamax vs Semax
Adamax (Experimental nootropic / ampakine-class research compound) and Semax (Synthetic ACTH(4-10) analog (heptapeptide)) are documented as co-studied in the PeptiDex library. This page puts the two entries side by side on class, molecular weight, half-life, origin, mechanism and studied research areas — every value taken from the entry it belongs to.
Why these two are co-studied
Cross-referenced for research context — not a usage or combination recommendation.
At a glance
| Attribute | Adamax | Semax |
|---|---|---|
| Compound class | Experimental nootropic / ampakine-class research compound | Synthetic ACTH(4-10) analog (heptapeptide) |
| Research category | Cognitive & Nootropic | Cognitive & Nootropic |
| Length (amino acids) | Not documented | 7 amino acids |
| Molecular weight | Not documented | 813.9 g/mol |
| Half-life | Not documented | ~2-5 minutes (plasma) |
| Origin | Adamax is described in nootropic circles as an experimental compound reportedly related to the ampakine family; reliable primary literature and manufacturer documentation are scarce. | Semax was developed in Russia (Institute of Molecular Genetics, Russian Academy of Sciences) as a synthetic analog of a fragment of adrenocorticotropic hormone (ACTH 4-10) with an added Pro-Gly-Pro tail for stability. It is marketed in Russia and some neighboring countries. |
“Not documented” means the PeptiDex entry records no value for that field. Nothing on this page is estimated, and no figure is carried over from one compound to the other.
How Adamax works
Ampakines as a class are positive allosteric modulators of AMPA-type glutamate receptors, which can enhance excitatory synaptic transmission. Publicly available, verifiable data specific to Adamax are very limited, so its precise structure and mechanism cannot be stated with confidence.
How Semax works
Semax is an analog of the ACTH(4-10) melanocortin fragment but is described as being devoid of hormonal (corticotropic) activity. Research reports that it influences brain-derived neurotrophic factor (BDNF) and its receptor TrkB, modulates the expression of neurotrophin-related and immune genes, and may affect monoaminergic systems. It has been studied for neuroprotective and nootropic effects, potentially via effects on the melanocortin system.
Mechanistic descriptions reflect published research-literature understanding and are quoted from each compound's own entry. Much peptide research is preclinical (in-vitro or animal-model); mechanism in humans may differ and is not established for many compounds.
Where each one appears in the literature
The research contexts each entry documents. Listing a research area is not a claim of efficacy or a therapeutic indication, and the two lists are not scored against each other.
What sets each apart
Adamax
Adamax is distinguished mainly by how little verifiable information exists about it, in contrast to better-characterized peptides in this class.
Semax
Semax is a melanocortin (ACTH)-derived peptide oriented toward neuroprotection and cognition, whereas Selank derives from tuftsin and is oriented toward anxiolysis.
Frequently asked questions
What is Adamax?
Adamax is a synthetic peptide in the Semax/ACTH-analog family, described as an N-acetylated, adamantane-modified analog developed to extend the short duration of action of Semax. It is studied for cognition and neuroprotection endpoints, primarily via a proposed BDNF-TrkB mechanism.
How does Adamax differ from Semax?
Adamax carries additional stabilizing modifications (an N-acetyl group and an adamantane moiety) intended to lengthen its duration of action relative to Semax. Vendor and preclinical descriptions report a longer effective window per dose than Semax, though the underlying data are limited.
Is Adamax the same as P21?
No, although some vendor pages conflate them. Adamax is an adamantane-modified Semax-family analog, whereas P21 (P021) is a separate CNTF-derived neurotrophic mimetic; they share a general interest in BDNF-linked mechanisms but are chemically distinct.
What is Semax and what is it studied for?
Semax is a synthetic heptapeptide that adds a stabilizing Pro-Gly-Pro tail to the ACTH(4-7) fragment, developed at the Russian Academy of Sciences. It is studied in research models of cognition, attention, memory, and neuroprotection, where it is reported to upregulate BDNF and NGF messenger RNA in the hippocampus and cortex.
How does Semax achieve long effects despite a very short half-life?
The parent peptide has a plasma half-life of only about 2-5 minutes, yet its transcriptional effects on neurotrophic factors are measured over hours. The Pro-Gly-Pro tail slows peptidase cleavage relative to the native ACTH(4-7) fragment, allowing enough exposure to drive downstream BDNF/NGF signaling that outlasts the peptide itself.
Why is intranasal delivery emphasized in Semax research?
Intranasal administration provides direct nose-to-brain transport, achieving rapid CNS exposure without depending on blood-brain-barrier crossing from systemic circulation. Given the peptide's very short plasma half-life, this route is a common design choice in cognition and neuroprotection studies.
Answers are the ones published on each compound's own PeptiDex entry. They are educational summaries of research-literature context and are not medical advice.